Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations
Conditions: Delayed Graft Function; End Stage Renal Disease; Kidney Transplantation Interventions: Drug: Goal-Directed Fluid Therapy (GDFT); Drug: Regular Fluid Therapy Sponsors: RenJi Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hospitals | Kidney Transplant | Kidney Transplantation | Research | Transplants | Urology & Nephrology